UnknownPhase 4

Additive Hemostatic Efficacy of EndoClot After EMR or ESD in the Gastrointestinal Tract

288 participantsStarted 2023-09

Plain-language summary

The investigators want to verify in a randomised trial, the effectiveness of EndoClotTM in preventing post-procedural bleeding after EMR (Endoscopic Mucosal Resection) or ESD (Endoscopic Submucosal Dissection) for sessile lesions \>20 mm in the right colon

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * \>18 years old * lesions suitable for EMR or ESD * \> 20 mm * site in the right colon Exclusion Criteria: * Severe cardiovascular pathologies * Liver and Urinary dysfunctions * Hematologic diseases * Pregnancy and breast feeding * impossible follow-up * platelet and coagulation disorders (PLT \< 50 x 109/L, INR \> 2) * Sensitivity or allergy to the drug

What they're measuring

effectiveness of EndoClotTM in preventing post-procedural bleeding

Timeframe: 14 days

Trial details

NCT IDNCT02688699

SponsorUniversity of Turin, Italy

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-02

Contact for this trial

Alberto Arezzo, MD

+393358378243 alberto.arezzo@unito.it

View on ClinicalTrials.gov More Colonic Polyp trials